Dr. Kerkar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 667
Rochester, NY 14642Phone+1 585-275-2647Fax+1 585-275-0707
Summary
- Dr. Nanda Kerkar is a Professor of Pediatrics and is Director of the Pediatric Liver Disease and lIver Transplant Program at Golisano Childrens Hospital at Strong Memorial in Rochester, University of Rochester Medical Center, New York. She received her medical degree from University of Calcutta School of Medicine, did her post graduate training at King's College, London, United Kingdom and has been in practice for 15 years in the United States. She specializes in pediatric hepatology and liver transplantation. She has a strong interest in autoimmune liver disease, Wilson disease and cholestatic diseases. apart from working with patients she is committed to clinical research and has over a 100 publications.
Education & Training
- University of Calcutta School of MedicineClass of 1988
Certifications & Licensure
- NY State Medical License 2002 - 2026
- CA State Medical License 2015 - 2025
- MA State Medical License 2023 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
- American Board of Pediatrics Pediatric Transplant Hepatology
Clinical Trials
- The REPLACE Registry for Cholbam® (Cholic Acid) Start of enrollment: 2017 Jul 10
Roles: Contact
Publications & Presentations
PubMed
- Adult provider role in transition of care for young adult pediatric recipients of liver transplant: An expert position statement.Jennifer Vittorio, Beverly Kosmach-Park, Sharad Wadhwani, Whitney Jackson, Nanda Kerkar
Hepatology Communications. 2024-08-01 - Hepatitis C Virus and Molecular Mimicry.Lynette Goh, Nanda Kerkar
Pathogens. 2024-06-22 - 5 citationsEvent-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.Bettina E Hansen, Shannon M Vandriel, Pamela Vig, Will Garner, Douglas B Mogul
Hepatology. 2024-06-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: